The recycled rhetoric questioning the role of the biopharmaceutical industry in the discovery and development of innovative medicines continues to rear its ugly head in the ongoing discussion about the high cost of health care and what to do about it. But, for patients with unmet medical needs, this continued skepticism is merely a distraction.
Most patients understand that their hope for future cures relies on the work that biopharma does to translate basic science into deliverable treatments and medicines. That understanding is backed by facts.